Please ensure Javascript is enabled for purposes of website accessibility
REVIEW PAPER
Procedure in the prevention and nurturing of inflammatory changes of oral mucositis among patients treated for oncological conditions
 
More details
Hide details
1
Clinical Oncology Ward, St. John’s Cancer Centre, Lublin, Poland
 
 
Submission date: 2015-06-02
 
 
Final revision date: 2016-04-24
 
 
Acceptance date: 2016-04-29
 
 
Publication date: 2016-07-11
 
 
Medical Studies 2016;32(2):145-149
 
KEYWORDS
TOPICS
ABSTRACT
Oral mucositis is a serious complication occurring in the process of chemotherapy and/or radiotherapy. Ailments related to oral mucositis may bring about pain, reduce the amount of food intake, and eventually deteriorate the quality of life. This complication arises after radiotherapy, chemotherapy, transplantation of haematopoietic stem cells, and after molecularly targeted therapy. These symptoms may be the result of delay of treatment or dose reduction of successive cycles of chemotherapy, which, consequently, may have an impact on oncological treatment.
REFERENCES (36)
1.
Jarosz M, Sajór I. Żywienie a choroba nowotworowa. Poradnik dla pacjentów i ich rodzin. Primopro, Warsaw 2013.
 
2.
Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST. Mucositis Study Section of the Multinational Association for Supportive Care in Cancer: International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004; 100 (9 Suppl): 2026-46.
 
3.
Raber-Durlacher JE. Current practicers for management of oral mucositis in cancer patients. Support Care Cancer 1999; 7: 71-4.
 
4.
Eisen D, Essel J, Broun ER. Oral cavity complications of bone marrow transplantation. Sem Cutan Med Surg 1997; 16: 265-72.
 
5.
Dyszkiewicz M, Shaw H. Ocena stanu błony śluzowej jamy ustnej u pacjentów leczonych radio- i chemioterapią. Dent Med Probl 2009; 46: 89-93.
 
6.
Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 2012; 62: 400-22.
 
7.
Szponar E, Bobowicz Z, Ramlau C, Broekere-Biesiadka B. Leczenie cytostatykami a stan błony śluzowej jamy ustnej. Badania kliniczne, cytologiczne i mikologiczne. Mag Stomatol 1997; 5: 17-9.
 
8.
Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol 2003; 39: 91-100.
 
9.
Cioch M. Uszkodzenie bariery śluzówkowej w następstwie intensywnego leczenia cytostatycznego. Onkol Pol 2001; 4: 85-8.
 
10.
Petersond E. New strategies for management of oral mucositis in cancer patients. J Support Oncol 2006; 4 Suppl. 1: 9-13.
 
11.
Bergman OJ. Oral infections and fever in immuno-compromised patients with haematologic malignancies. Eur J Clin Microbiol Inf Dis 1989; 3: 207-13.
 
12.
Donnelly JP, Bellm LA, Epstein JB, Sonis ST, Symonds RP. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 2003; 3: 405-12.
 
13.
Owlia F, Kazemeini S, Gholami N. Prevention and management of mucositis in patients with cancer: a review article. Iran J Cancer Prev 2012; 5 (Suppl. 4): 216-20.
 
14.
Monnerat C, Ketterer N. Zapalenie błon śluzowych. In: Podręcznik stanów nagłych w onkologii. Paris A, Schrijvers D, Fabrice A, Rottey S (eds.). Medi Page, Warsaw 2006.
 
15.
Wronkowski Z, Brużewicz S. Chemioterapia i radioterapia. PZWL, Warsaw 2007.
 
16.
Dreizen S, Menkin DJ, Keating MJ, McCredie KB, O’Neill PA. Efects of antileukaemia chemiotherapy on marrow, blood and oral granulocyte counts. Oral Surg Oral Med Oral Pathol 1991; 71: 45-9.
 
17.
Köstler WJ, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy and radiotherapy: options for prevention and treatment. CA Cancer J Clin 2001; 51: 290-315.
 
18.
Łuczak M, Swoboda-Kopeć E (eds.). Wybrane zagadnienia z mikrobiologii jamy ustnej. Czelej, Lublin 2004.
 
19.
Bossola M. Nutritional interventions in head and neck cancer patients undergoing chemoradiotherapy: a narrative review. Nutrients 2015; 7 (Suppl. 1): 265-76.
 
20.
Sieracki RL, Voelz LM, Johannik TM, Kopaczewski DM, Hubert K. Development and implementation of an oral care protocol for patients with cancer. Clin J Oncol Nurs 2009; 13: 718-22.
 
21.
Olszewska K, Mielnik-Błaszczak M. Liczebność drożdży z rodzaju Candida albicans w ślinie u dzieci w okresie neutropenii wywołanej leczeniem przeciwnowotworowym. Dent Med Probl 2014; 51: 178-86.
 
22.
Borgmann A, Emminger W, Emminger-Schmidmeier W, Peters C, Gatterer-Menz I, Henze G, Gadner H. Influence of fractionated total body irradiation on mucosal toxicity in intensified conditioning regiments, for autologous bone marrow transplantation in pediatric cancer patients. Klin Padiatr 1994; 206: 299-302.
 
23.
Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M. Prevention of oral mucositis in patients treated with high dose chemiotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 1994; 30 B: 93-7.
 
24.
Oberoi S, Zamperlini-Netto G, Beyene J, Treister NS, Sung L. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One 2014; 9 (Suppl. 9): 1-10.
 
25.
Epstein JB, Vickars L, Spinelli J, Reece D. Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukaemia and bone marrow transplantation. Oral Surg Oral Med Oral Pathiol 1992; 73: 682-9.
 
26.
Rutkauskas JS, Davis JW. Effects of chlorhexidine during immunosuppressive chemiotherapy. A preliminary report. Oral Surg Oral Med Oral Pathol 1993; 76: 441-8.
 
27.
Nowacińska B. Zmiany w jamie ustnej u dzieci chorych na białaczkę w przebiegu chemioterapii. Czas Stomat 1989; 42: 436-40.
 
28.
Meurman JH, Laine P, Murtomaa H, Lindqvist C, Torkko H, Teerenhovi L, Pyrhönen S. Effect of antiseptic mouthwashes on some clinical and microbiological findings in the mouths of lymphoma patients receiving cytostatic drugs. J Clin Periodontol 1991; 18: 587-91.
 
29.
Laine P, Heurman JH, Hurtomaa H, Lindqvist CH, Tork-ko H, Pyrhonen S, Teerenhovi L. One year trial of the effects of rinsing with an amine fluoride stannous – fluoride – containing mouthwash on gingival index scores and salivary microbial counts in lymphoma patients receiving cytostatic drugs. J Clin Periodontol 1993; 20: 1-7.
 
30.
Laine P, Heurman JH, Hurtomaa H, Lindqvist CH, Torkko H, Pyrhonen S, Teerenhovi L, Eilers J, Harris D, Henry K, Johnson LA. Evidence-based interventions for cancer treatment-related mucositis: putting evidence into practice. Clin J Oncol Nurs 2014; 18: 80-96.
 
31.
Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G, van Bokhorst-de van der Schueren MA, von Meyenfeldt M; DGEM (German Society for Nutritional Medicine), Zürcher G, Fietkau R, Aulbert E, Frick B, Holm M, Kneba M, Mestrom HJ, Zander A; ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr 2006; 25: 245-59.
 
32.
Swoboda-Kopeć E, Łuczak M (eds.). Wybrane zagadnienia z mikrobiologii jamy ustnej. Czelej, Lublin 2004.
 
33.
Malicka B, Ziętek M, Grzebieluch W. Zastosowanie chlorheksydyny w stomatologii. Dent Med Probl 2005; 42: 497-505.
 
34.
Cheng KF, Molassiotis A, Chang AM, Wai WC, Cheung SS. Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in pediatric cancer patients. Eur J Cancer 2001; 37: 2056-63.
 
35.
Kaźmierczak B. Problemy pielęgnacyjne pacjentów w trakcie chemioterapii. In: Problemy pielęgnacyjne pacjentów z chorobą nowotworową. Koper A, Wrońska I (eds.). Czelej, Lublin 2003.
 
36.
Jędrusik Z, Koper A, Kaźmierczak B, Tujakowski J. Opieka pielęgniarska w chemioterapii. In: Pielęgniarstwo onkologiczne. Koper A (ed.). PZWL, Warsaw 2011.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top